Schneider Jennifer bought VRTX
May 15, 2024 · Form 4 insider transaction
Schneider Jennifer bought 922 shares of Vertex Pharmaceuticals Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
922
Price
$0.00
Total value
N/A
InsiderSchneider Jennifer
Role—
SecurityCommon Stock
Transaction codeA: Grant or award
Transaction dateMay 15, 2024
Filing dateMay 17, 2024
Shares owned after922
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date.